Sort
21,453 grants matching “tuberculosis”
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors
$198,146Michael N Bates · University Of California Berkeley · R01 · FY2012 · ES
Vaccination strategies against pulmonary tuberculosis
$198,126Alistair John Ramsay · Lsu Health Sciences Center · R01 · FY2008 · AI
Vaccination strategies against pulmonary tuberculosis
$198,126Alistair John Ramsay · Lsu Health Sciences Center · R01 · FY2009 · AI
IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
$198,125Laurel L Lenz · National Jewish Health · R21 · FY2013 · AI
Genomics Training and Career Development for African Scientists
$198,057Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2017 · AI
Coenzyme F420, helping mycobacteria find a niche in humans
$198,000Michael Berney · Albert Einstein College Of Medicine · R21 · FY2023 · AI
Siderophore-dependent inhibitors of Mycobacterium tuberculosis
$198,000Michael Niederweis · University Of Alabama At Birmingham · R21 · FY2021 · AI
GLYOXYLATE SHUNT AND PARASITISM BY MYCOBACTERIUM SPP
$197,928Cornell University Ithaca · R01 · FY2002 · AI
The Effectiveness and Cost-Effectiveness of Implementing Evidence-Based Depression Treatment within the TB Care Platform in South Africa: A Hybrid Effectiveness-Implementation Trial
$197,850Annika Claire Sweetland · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2025 · AI
Transmission dynamics of Mycobacterium tuberculosis
$197,828Michael Shiloh · Ut Southwestern Medical Center · R21 · FY2019 · AI
The influence of air pollution on lung health among people living with HIV.
$197,812Crystal North · Massachusetts General Hospital · K23 · FY2022 · HL
Structure of Malaria Parasite RNA polymerase
$197,738Katsuhiko Murakami · Pennsylvania State University, The · R21 · FY2023 · AI
Entry Mechanisms of Mycobacterium marinum
$197,735Texas A&M University Health Science Ctr · R01 · FY2005 · AI
Roles for Exosomes in Adaptive Immunity to M. tuberculosis
$197,657Pamela A Wearsch · Case Western Reserve University · R21 · FY2013 · AI
Evaluation of novel tuberculosis screening strategies for people living with HIV
$197,640Christina Yoon · University Of California, San Francisco · K23 · FY2017 · AI
Safety and tolerability of new and repurposed drugs for MDR-TB treatment
$197,640Gustavo Eduardo Velasquez · University Of California, San Francisco · K08 · FY2023 · AI
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
$197,640Jana Jarolimova · Massachusetts General Hospital · K23 · FY2023 · AI
Evaluation of novel tuberculosis screening strategies for people living with HIV
$197,640Christina Yoon · University Of California, San Francisco · K23 · FY2018 · AI
NK cells and IL-15 in the human innate immune response to tuberculosis
$197,625Peter F. Barnes · University Of Texas Hlth Ctr At Tyler · R21 · FY2007 · HL
Role of metabolic Me-macrophages in the pathogenesis of tuberculosis during diabetes
$197,530Blanca I Restrepo · University Of Texas Hlth Sci Ctr Houston · R21 · FY2021 · AI
Molecular analysis of the adaptive immune response to tuberculosis
$197,500Spyros A Kalams · Vanderbilt University Medical Center · R21 · FY2017 · AI
Defining the role of toxin-antitoxin systems in persistence of Burkholderia pseudomallei
$197,500Alfredo G Torres · University Of Texas Med Br Galveston · R21 · FY2021 · AI
Targeting protein-protein interactions as drug targets
$197,500Michael D Burkart · University Of California, San Diego · R21 · FY2022 · AI
Multidimensional Analysis of Immune Status of Latent M. Tuberculosis Infection
$197,500Yueh-Hsiu Chien · Stanford University · R21 · FY2017 · AI
Inhibition of Macrophage Innate Immunity in Tuberculosis
$197,500University Of Iowa · R01 · FY2003 · AI